JAK2 and myeloproliferative disorder: Considering that the JAK2 V617F mutation is a characteristic gene mutation of myeloproliferative neoplasms [18–21], the emergence of the JAK2 V617F mutation might be associated with the appearance of a myeloid phenotype.